Regulatory Press Releases

Torbjörn Sköld has informed the board of his intentions to leave his role as CEO in June 2025 to focus on new professional opportunities. Torbjörn Sköld has a notice period of six months and will continue in his current role during that time. The board has now begun the process of recruiting his successor. "Torbjörn has played a central role in further developing and strengthening...

Stille AB (publ) proudly unveils the imagiQ3™, the next generation of C-arm tables, designed to set new standards in visualization, operating room efficiency and patient safety. Stille is proud to announce the launch of imagiQ3™, the next generation of advanced C-arm tables. With a commitment to product leadership and innovation, the new table is designed for ultimate visualization and...

Stille AB (publ) today presents the report for the third quarter 2024. Revenue amounted to MSEK 127.9 (70.1) driven by strong organic growth in surgical instruments and the successful acquisition of Fehling. Total growth amounted to 82.4 percent, of which 7.4 percent was organic growth.“Organic growth remained robust, despite high comparable figures and slightly lower demand in the surgical table...

Stille AB (publ) today presents the report for the second quarter and first half of the year 2024. Revenue amounted to MSEK 142.6 (75.1) driven by strong organic growth in surgical instruments and the acquisition of Fehling. Total growth amounted to 89.9 percent, of which 7.4 percent was organic growth.“It is encouraging to see that organic growth remains robust, despite strong comparable figures.&rdquo...

The Annual General Meeting 2024 in Stille AB was held on Wednesday, May 8th at Eskilstunavägen 34 in Torshälla. The main resolutions passed at the Annual General Meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the Annual General Meeting and the complete proposals, which are available on the company’s...